Literature DB >> 8767738

Enantiomer separation of drugs by electrokinetic chromatography.

H Nishi1.   

Abstract

This review surveys the enantiomer separation of drugs by electrokinetic chromatography (EKC). EKC is one option of capillary electrophoretic (CE) techniques, which permits the separation of electrically neutral drugs. In enantiomer separation by EKC, ionic pseudo-stationary phases such as chiral micelles and proteins, which can migrate with its electrophoretic mobility and can interact with the solutes, are employed as chiral selectors. Addition of electrically neutral chiral selectors such as cyclodextrins and precolumn conversion of solutes into diastereomers are also successful in EKC. A brief theory of separation and modes of EKC enantiomer separation are described with some typical applications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8767738     DOI: 10.1016/0021-9673(95)01262-1

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  3 in total

Review 1.  Clinical and pharmaceutical applications of affinity ligands in capillary electrophoresis: A review.

Authors:  Chenhua Zhang; Ashley G Woolfork; Kyungah Suh; Susan Ovbude; Cong Bi; Marawan Elzoeiry; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2019-09-12       Impact factor: 3.935

2.  Cyclodextrin-modified micellar electrokinetic chromatography for the analysis of Esterom, a topical product consisting of hydrolyzed benzoylecgonine in propylene glycol.

Authors:  Jennifer L Razak; Heidi J Doyen; Craig E Lunte
Journal:  Electrophoresis       Date:  2003-06       Impact factor: 3.535

Review 3.  Chiral Capillary Electrokinetic Chromatography: Principle and Applications, Detection and Identification, Design of Experiment, and Exploration of Chiral Recognition Using Molecular Modeling.

Authors:  Sami El Deeb; Camilla Fonseca Silva; Clebio Soares Nascimento Junior; Rasha Sayed Hanafi; Keyller Bastos Borges
Journal:  Molecules       Date:  2021-05-11       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.